Cushing's Syndrome Therapeutics Market - Forecasts from 2016 to 2021
Cushing’s disease is a condition where the adrenal glands produce excess cortisol hormone or when there is too much cortisol in the body due to overmedication of glucocorticoids. A tumor in the pituitary gland, or in the adrenal glands, can also lead to excess cortisol in the body. It is more common in females than in males. Europe and the United states are the largest markets in the Cushing’s syndrome therapeutics space, due to a high incidence of adrenal insufficiency in these regions. Factors driving the market are lifestyle changes associated with increased urbanization, growing female population and growing awareness of the disease.
This section provides an anatomy of the research process followed for calculating market size and forecasts along with a list of the secondary data sources used and the primary inputs which were taken for data validation. It also provides an outline of the various segmentations which have been covered as part of the report.
In this section, the entire Cushing’s syndrome therapeutics market is explained along with the causes, diagnosis, and prevention of the disease, the various drivers, restraints and opportunities to its treatment market and the prevalence of the disease based on age, gender and region. A product pipeline of various therapeutic drugs has been mentioned along with innovations in the market. Certain regulations specific to the industry are also listed out, followed by a detailed scenario analysis.
Cushing’s syndrome Therapeutics Market has been segmented based on the type and geography as below:
- Surgical Treatment
- Pituitary Radiotherapy
- Medical Therapy
- North America
- South America
- Europe Middle East and Africa
- Middle East and Africa
- Asia Pacific
This Section deals with major players in the market, their market shares, products, growth strategies, financials, and recent investments among others. Key industry players in Cushings Syndrome Market are Novartis, Corcept Therapeutics Inc., HRA Pharma, and Ipsen among others.
2. Research Methodology
3. Executive Summary
4. Cushing’s Syndrome Industry Overview
4.1. Market Overview
4.2. Drivers, Restraints, and Opportunities
4.3. Industry Value Chain Analysis
4.4.1. By Age Group
4.4.2. By Gender
4.4.3. By Region
4.5. Product Pipeline
4.7. Industry Regulations
4.8. Scenario Analysis
5. Cushing’s Syndrome Therapeutics Market Forecast by Type (US$ million)
5.1. Surgical Treatment
5.2. Pituitary Radiotherapy
5.3. Medical Therapy
6. Cushing’s Syndrome Therapeutics Market Forecast by Geography (US$ million)
6.1.1. North America
6.1.2. South America
6.2. Europe Middle East and Africa
6.2.2. Middle East and Africa
6.3. Asia Pacific
7. Competitive Intelligence
7.1. Market Share Analysis
7.2. Investment Analysis
7.3. Recent Deals
7.4. Strategies of Key Players
8. Company Profiles
8.2. Corcept Therapeutics Inc.
8.3. HRA Pharma
8.5. Samaritan Pharmaceuticals, Inc.
8.6. StrongBridge Biopharma
Merkel Cell Carcinoma Pipeline Analysis 2018 (Q1) – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments
Hemochromatosis (Iron Overload) Pipeline Analysis 2018 – Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments